Suppression of the proliferation and migration of oncogenic ras-dependent cell lines, cultured in a three-dimensional collagen matrix, by flavonoid-structured molecules

Journal of Cancer Research and Clinical Oncology

Volumn 122, Issue 6, 1996, Pages 335-342

  Lu H Q ^a,b   Niggemann, B ^c   Zanker K S ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b BENGBU MEDICAL COLLEGE   (China)

^c Evangelisches Waldkrankenhaus   (Germany)

Author keywords

7 Hydroxycoumarin; Chemoprevention; Collagen matrix; Flavonoids; Genistein; Migration; Proliferation; ras

Indexed keywords

GENISTEIN; PHORBOL ESTER; QUERCETIN; UMBELLIFERONE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; RAT; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL MOVEMENT; COLLAGEN; CULTURE MEDIA; GENES, RAS; GENISTEIN; GUANOSINE TRIPHOSPHATE; HUMANS; INDICATORS AND REAGENTS; ISOFLAVONES; MAMMARY NEOPLASMS, EXPERIMENTAL; OXIDATION-REDUCTION; PROTO-ONCOGENE PROTEINS P21(RAS); QUERCETIN; RATS; TETRAZOLIUM SALTS; TUMOR CELLS, CULTURED; UMBELLIFERONES; URINARY BLADDER NEOPLASMS;

EID: 0029971019     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf01220800     Document Type: Article

References (38)

1. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fuami Y (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595
2. Avila MA, Velasco JA, Cansado J, Notario V (1994) Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res 54:2424-2428
3. Barbacid M (1987) ras genes. Annu Rev Biochem 56:779-827
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
5. Capon DJ, Chen EY, Levinson AD, Seeburg PT, Goeddel DV (1983) Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature 302:33-37
6. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y (1982) Direct activation of calcium-activated phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257:7847-7851
7. Czech J, Hoffmann D, Naik R, Sedlacek H (1995) Antitumoral activity of flavone L 86-8275. Int J Oncol 6:31-36
8. ras but does not affect their function or localization. Cancer Res 55:3295-3304
9. ras upon T-cell activation. Nature 346: 719-723
10. Egan SE, McClarty GA, Jarolim L, Wright JA, Spiro I, Hager G, Greenberg AH (1987) Expression of Ha-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells. Mol Cell Biol 7:830-837
11. Friedl P, Noble PB, Zänker KS (1993) Lymphocyte locomotion in three-dimensional collagen gels - comparison of three quantitative methods for analysing cell trajectories. J Immunol Methods 165:157-165
12. Friedl P, Noble PB, Walton PA, Laird DW, Chauvin PJ, Tabah RJ, Black M, Zänker KS (1995) Migration of coordinated cell clusters in mesenchymal and epithelial cancer explants in vitro. Cancer Res 55:4557-4560
13. Graziani Y, Erikson E, Erikson RL (1983) The effect of quercetin on the phosphorylation activity of Rous sacoma virus transforming gene product in vitro and in vivo. Eur J Biochem 135:583-589
14. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24
15. Hunter T (1995) Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80:225-236
16. Kahn J, Preis P, Waldman F, Tseng Jr A (1994) Coumarin modulates the cell-cycle progression of an MTV-EJras cell line. J Cancer Res Clin Oncol 120 [Suppl]:S19-S22
17. Koishi M, Hosokawa N, Sato M, Nakai A, Hirayoshi K, Hiraoka M, Abe M, Nagata K (1992) Quercetin, an inhibitor of heat shock protein synthesis, inhibits the acquisition of thermotolerance in a human colon carcinoma cell line. J Cancer Res 83:1216-1222
18. Kokron O, Maca S, Gasser G, Schmidt PR (1991) Cimetidine and coumarin therapy of renal cell carcinoma. Oncology 48:102-106
19. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
20. Lee PL, Johnson DE, Cousens LS, Fried VA, Williams LT (1989) Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science 245:57-60
21. Liotta LA (1988) H-ras p21 and the metastatic phenotype. J Natl Cancer Inst 80:468-469
22. Lü HQ, Zänker KS (1994) Decreased cell growth and expression of p21Ha-ras in RBA cells treated by 7-hydroxycoumarin (abstract). In: Proceedings of the 6th MCDB/ISU Symposium, Ames, Iowa, p 36.
23. Marshall ME, Moulton JS, Stagge SL, Weiss LM, Corcoran HL (1993) Phase I trial of 7-hydroxycoumarin (7-HC) for the treatment of advanced human malignancies- a progress report (abstract). J Irish Coll Physicians Surg 22 [Suppl 1]:71
24. Marshall ME, Kervin K, Benefield C, Umerani A, Albainy-Jenei S, Zhao Q, Khazaeli M (1994) Growth-inhibitory effects of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin on human malignant cell lines in vitro. J Cancer Res Clin Oncol 120 [Suppl]:S3-S10
25. Maslow DE (1987) Collagenase effects on cancer cell invasiveness and motility. Invasion Metastasis 7:297-310
26. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
27. Qureshi SA, Alexandropoulos K, Rim M, Joseph CK, Bruder JT, Rapp UF, Foster DA (1992) Evidence that Ha-ras mediates two distinguishable intracellular signals activated by v-src. J Biol Chem 267:17635-17639
28. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D, Boyd MR (1988) Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48:4827-4833
29. Sporn MB, Roberts AB (1985) Autocrine growth factors and cancer. Nature 313:745-747
30. Stossel TP (1993) On the crawling of animal cells. Science 260: 1086-1094
31. Thornes D, Daly L, Lynch G, Browne H, Tanner A, Keane F, O'Loughlin S, Corrigan T, Daly P, Edwards G, Breslin B, Browne HY, Shine M, Lennon F, Hanley J, McMurray N, Gaffney E (1989) Prevention of early recurrence of high risk malignant melanoma by coumarin. Eur J Surg Oncol 15: 431-435
32. Traganos F, Ardelt B, Halko N, Bruno S, Darzynkiewicz Z (1992) Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLZ-4 and HL-60 cells. Cancer Res 52:6200-6208
33. Watanabe T, Kondo K, Oishi M (1991) Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinase. Cancer Res 51:764-768
34. Wei YQ, Zhao X, Kariya Y, Fukada H, Teshigawara K, Uchida A (1994) Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res 54:4952-4957
35. Yarden Y, Ullrich A (1988) Molecular analysis of signal transduction by growth factors. Biochemistry 27:3113-3119
36. Yoshida M, Sakai T, Hosokawa N, Matsumoto K, Fujioka A, Nishino H, Aoike A (1990) The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett 260:10-13
37. Zänker KS (1993) Coumarin(s) interface between cell growth inhibition, expression of oncogenes, tumor cell locomotion and cell-to-cell communication, J Irish Coll Physicians Surg 22 [Suppl 1]:51-55
38. Zänker KS, Blumel G, Lange J, Siewert JR (1984) Coumarin in melanoma patients: an experimental and clinical study. Drugs Exp Clin Res 10:767-774